Company
Ovation
Accelerating precision medicine with human genomic data at scale
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Customers
- life sciences researchers
- Legal name
- Ovation.io, Inc.
- ovation.io (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Ovation generates high-value genomic and other omics data linked to rich longitudinal clinical data to increase drug discovery success rates across therapeutic areas.
Funding snapshot
- Total raised
- $31MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $696K2024-09-11
Funding rounds
- Round, 2024
- $696K2024-09-11, SEC form D sold, 6 investors
- Round, 2020
- $21.3M2020-09-28, SEC form D sold, 7 investors
- Round, 2019
- $3.1M2019-08-28, SEC form D sold, 7 investors
- Round, 2019
- $5.9M2019-02-28, SEC form D sold, 14 investors
Products
- Web
- Ovation LIMS
Loading relationship preview